From: CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication
Relative risk estimates | ||||
---|---|---|---|---|
N, (%) | Adj. HR | 95 % CI | ||
Intervention versus control status | ||||
Control | 644 (31.38) | 1.00 | Reference | |
Intervention | 634 (30.90) | 1.00 | 0.90 | 1.12 |
Possible confounders: | ||||
Gender | ||||
Men | 561 (43.90) | 1.00 | Reference | |
Women | 717 (56.10) | 1.36 | 1.21 | 1.53 |
Age | ||||
≤ mean age 57.3 years | 685 (32.14) | 1.00 | Reference | |
>mean age 57.3 years | 593 (30.06) | 0.92 | 0.82 | 1.03 |
Civil status | ||||
Living together | 806 (63.46) | 1.00 | Reference | |
Living alone | 464 (36.54) | 1.26 | 1.12 | 1.42 |
Social status (SES) | ||||
Low | 576 (38.07) | 1.00 | Reference | |
Middle | 397 (30.70) | 0.86 | 0.80 | 0.93 |
High | 305 (23.50) | 0.43 | 0.37 | 0.49 |
Charlson Co-morbidity index (CCI) | ||||
0 | 985 (28.89) | 1.00 | Reference | |
1 | 197 (41.65) | 1.25 | 1.14 | 1.37 |
> 1 | 96 (43.44) | 2.50 | 2.38 | 2.62 |
Prescription of AD or AX at least once during the 4 months period before baseline | ||||
No | 775 (21.78) | 1.00 | Reference | |
Yes | 503 (92.12) | 18.52 | 16.12 | 21.27 |
Total 1,278 (31.14) |